These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 2146282)
21. Physiological levels and action of dehydroepiandrosterone in Yucatan miniature swine. Tagliaferro AR; Ronan AM Am J Physiol Regul Integr Comp Physiol; 2001 Jul; 281(1):R1-9. PubMed ID: 11404272 [TBL] [Abstract][Full Text] [Related]
22. Testosterone deficiency in young men: marked alterations in whole body protein kinetics, strength, and adiposity. Mauras N; Hayes V; Welch S; Rini A; Helgeson K; Dokler M; Veldhuis JD; Urban RJ J Clin Endocrinol Metab; 1998 Jun; 83(6):1886-92. PubMed ID: 9626114 [TBL] [Abstract][Full Text] [Related]
23. Two-month treatment of obese subjects with the oral growth hormone (GH) secretagogue MK-677 increases GH secretion, fat-free mass, and energy expenditure. Svensson J; Lönn L; Jansson JO; Murphy G; Wyss D; Krupa D; Cerchio K; Polvino W; Gertz B; Boseaus I; Sjöström L; Bengtsson BA J Clin Endocrinol Metab; 1998 Feb; 83(2):362-9. PubMed ID: 9467542 [TBL] [Abstract][Full Text] [Related]
24. Relationship of resting metabolic rate to body composition and protein turnover. Welle S; Nair KS Am J Physiol; 1990 Jun; 258(6 Pt 1):E990-8. PubMed ID: 2360629 [TBL] [Abstract][Full Text] [Related]
25. Dehydroepiandrosterone sulfate levels in women. Relationships with body mass index, insulin and glucose levels. Al-Harithy RN Saudi Med J; 2003 Aug; 24(8):837-41. PubMed ID: 12939667 [TBL] [Abstract][Full Text] [Related]
26. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause. Stomati M; Monteleone P; Casarosa E; Quirici B; Puccetti S; Bernardi F; Genazzani AD; Rovati L; Luisi M; Genazzani AR Gynecol Endocrinol; 2000 Oct; 14(5):342-63. PubMed ID: 11109974 [TBL] [Abstract][Full Text] [Related]
27. Divergent effect of dehydroepiandrosterone on energy intakes of Zucker rats. Wright BE; Browne ES; Svec F; Porter JR Physiol Behav; 1993 Jan; 53(1):39-43. PubMed ID: 8434067 [TBL] [Abstract][Full Text] [Related]
28. Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomized, double blind trial. Hunt PJ; Gurnell EM; Huppert FA; Richards C; Prevost AT; Wass JA; Herbert J; Chatterjee VK J Clin Endocrinol Metab; 2000 Dec; 85(12):4650-6. PubMed ID: 11134123 [TBL] [Abstract][Full Text] [Related]
29. Adiponectin is involved in the protective effect of DHEA against metabolic risk in aged rats. Pérez-de-Heredia F; Sánchez J; Priego T; Nicolás F; Portillo Mdel P; Palou A; Zamora S; Garaulet M Steroids; 2008 Oct; 73(11):1128-36. PubMed ID: 18534650 [TBL] [Abstract][Full Text] [Related]
30. The contribution of body composition, substrates, and hormones to the variability in energy expenditure and substrate utilization in premenopausal women. Astrup A; Buemann B; Christensen NJ; Madsen J; Gluud C; Bennett P; Svenstrup B J Clin Endocrinol Metab; 1992 Feb; 74(2):279-86. PubMed ID: 1530952 [TBL] [Abstract][Full Text] [Related]
32. Biotransformation of oral dehydroepiandrosterone in elderly men: significant increase in circulating estrogens. Arlt W; Haas J; Callies F; Reincke M; Hübler D; Oettel M; Ernst M; Schulte HM; Allolio B J Clin Endocrinol Metab; 1999 Jun; 84(6):2170-6. PubMed ID: 10372727 [TBL] [Abstract][Full Text] [Related]
33. Panhypopituitarism as a model to study the metabolism of dehydroepiandrosterone (DHEA) in humans. Young J; Couzinet B; Nahoul K; Brailly S; Chanson P; Baulieu EE; Schaison G J Clin Endocrinol Metab; 1997 Aug; 82(8):2578-85. PubMed ID: 9253337 [TBL] [Abstract][Full Text] [Related]
34. Lack of effect of dehydroepiandrosterone in obese men. Usiskin KS; Butterworth S; Clore JN; Arad Y; Ginsberg HN; Blackard WG; Nestler JE Int J Obes; 1990 May; 14(5):457-63. PubMed ID: 2143499 [TBL] [Abstract][Full Text] [Related]
35. The estrogen antagonist EM-652 and dehydroepiandrosterone prevent diet- and ovariectomy-induced obesity. Lemieux C; Picard F; Labrie F; Richard D; Deshaies Y Obes Res; 2003 Mar; 11(3):477-90. PubMed ID: 12634448 [TBL] [Abstract][Full Text] [Related]
36. Short-term dehydroepiandrosterone treatment increases platelet cGMP production in elderly male subjects. Martina V; Benso A; Gigliardi VR; Masha A; Origlia C; Granata R; Ghigo E Clin Endocrinol (Oxf); 2006 Mar; 64(3):260-4. PubMed ID: 16487434 [TBL] [Abstract][Full Text] [Related]
37. Endocrine effects of oral dehydroepiandrosterone in men with HIV infection: a prospective, randomized, double-blind, placebo-controlled trial. Poretsky L; Brillon DJ; Ferrando S; Chiu J; McElhiney M; Ferenczi A; Sison MC; Haller I; Rabkin J Metabolism; 2006 Jul; 55(7):858-70. PubMed ID: 16784956 [TBL] [Abstract][Full Text] [Related]
38. The association of dehydroepiandrosterone, obesity, waist-hip ratio and insulin resistance with fatty liver in postmenopausal women--a hyperinsulinemic euglycemic insulin clamp study. Saruç M; Yüceyar H; Ayhan S; Türkel N; Tuzcuoglu I; Can M Hepatogastroenterology; 2003; 50(51):771-4. PubMed ID: 12828082 [TBL] [Abstract][Full Text] [Related]
39. Effects on metabolic rate and fuel selection of a selective beta-3 agonist (ICI D7114) in healthy lean men. Goldberg GR; Prentice AM; Murgatroyd PR; Haines W; Tuersley MD Int J Obes Relat Metab Disord; 1995 Sep; 19(9):625-31. PubMed ID: 8574272 [TBL] [Abstract][Full Text] [Related]
40. Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology. Labrie F; Bélanger A; Cusan L; Candas B J Clin Endocrinol Metab; 1997 Aug; 82(8):2403-9. PubMed ID: 9253308 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]